Do you want to help others with sickle cell? Join us in learning more about blood health. By taking part in our study, you may help us discover new ways to treat blood disorders like sickle cell disease. Your participation could bring hope to many. Plus, you'll receive compensation for your time.

We're exploring what college students in North Carolina know about taking care of their teeth and gums. We want to understand how students from different areas of the state think about oral health and how visiting or not visiting a dentist might influence their knowledge and dental care habits.

Have you recently graduated as a nurse and taken the NURS510 course on managing critically ill patients at UNC Chapel Hill? If yes, we'd love for you to join our study! We're looking at how new nurses experience ACLS simulation, and your insights could really help us improve training for future nurses.

Do you want to help in the design of a new device that can electronically measure and track your strength? We are testing a new system that uses an electronic resistance exercise band and an 'app' designed for older adults to improve strength and prevent weakness.

Do you have asthma and sometimes experience attacks? You might qualify for our study testing a new rescue treatment. We're exploring if a treatment can help manage your symptoms. Join us to help shape future asthma care.

Volunteers Needed! The ZENITH study may be an option for people 12-55 years old who are allergic to peanut.

This study aims to learn how nurses in the Neonatal Critical Care Center (NCCC) at UNC Hospitals in Chapel Hill use and think about Kangaroo Care, which is when a parent holds their premature baby skin-to-skin. Kangaroo Care can help babies sleep better, reduce stress, improve breastfeeding, and support growth. Most research focuses on how it helps babies, but we want to know more about how nurses use it during their work. We will interview experienced NCCC nurses to find out how they introduce Kangaroo Care to families, how often they use it, what makes it easier or harder to do, and what changes they notice in the babies. The goal is to help hospitals support nurses and families better in the NCCC.

The purpose of this study is to see if etentamig is safe and to identify the optimal etentamig dose when combined with daratumumab in participants with Newly Diagnosed Multiple Myeloma (NDMM) who are not eligible for transplant.

We want to learn about the eating habits and nutrition of men living with hypertension in North Carolina. By taking a 20-minute survey on the computer or your mobile device, you will help us better understand nutrition in men living with hypertension in North Carolina. If you are interested, please reach out to us.

Are you 18 years or older and diagnosed with HER2+, clinical stage T1c-T3 (or Tx) and nodal stage N0-N1 breast cancer and prior to surgery did you received chemotherapy in combination with Trastuzumab for a minimum of 12 weeks? If so, you may be eligible for a research study evaluating the effectiveness of 6 months of HER2-targeted medications (trastuzumab with or without pertuzumab) versus 12 months of HER2-targeted medications at reducing the risk of breast cancer coming back or death in patients.